The QualityStocks Daily Newsletter for Wednesday, Nov. 17th 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


BullRally (CMGR)


OTC Picks (SLRW)


Momentum Traders (CACB)

The QualityStocks Daily

VirtualScopics Inc. (VSCP)

SmallCap Voice and OTC Picks reported earlier on VirtualScopics Inc. (VSCP), and we highlight the Company, here at the QualityStocks Daily Newsletter.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. The Company has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. VirtualScopics Inc. trades on the NASDAQ Capital Market. They have their headquarters in Rochester, New York.

The Company’s services support all aspects of imaging in clinical trials, from design to FDA submission, pre-clinical through Phase IV. Their computer-assisted analysis techniques provide superior precision and reproducibility. This enables faster and more reliable detection of disease progression or therapeutic benefit, accelerating the clinical trial process, and providing a basis for future diagnostic applications.

Their proprietary software algorithms can process hundreds of separate medical images taken during an MRI or CT session into a single, anatomically accurate three-dimensional model. This provides clinical researchers a previously unobtainable source of reproducible data including the characterization of minute changes over time.

The Company is a leading imaging core lab providing central reads and quantitative imaging solutions for drug and medical device clinical trials. Therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, and cardiovascular studies utilizing MRI, PET, CT, Ultrasound, and X-Ray imaging modalities. Advanced semi-automated analysis software is used in conjunction with expert technicians and radiologists to quantify image-based biomarkers to deliver precise and repeatable measurements. This delivers the opportunity for compressed trial time, reduced subject sample size, real-time reads, and the ability to prove drug or device efficacy earlier.

Recently, PPD, Inc. and VirtualScopics, Inc. announced a strategic alliance to deliver a comprehensive set of clinical and medical imaging services that will enable biopharmaceutical companies to make faster, more confident decisions on the development of their oncology compounds, creating time and cost efficiencies. This partnership will provide seamless integration of technologies and processes, giving biopharmaceutical companies near real-time, consistent and reliable medical imaging information to expedite their drug development programs.

The alliance with VirtualScopics Inc. will enhance PPD’s ability to provide clients with the full service, integrated solutions needed to progress drug development from early phase to regulatory approval through an innovative, patented algorithm-based approach to image processing and biomarker measurement. PPD’s strong operational and medical expertise and global footprint offer VirtualScopics an opportunity to integrate medical imaging and clinical services and grow their strong customer base.

VirtualScopics Inc. (VSCP) closed Wednesday’s trading session at $1.40, down 2.10%, on 80,452 volume with 143 trades.  The average volume for the last 60 days is 70,151.  The 52-week low/high is $0.79/$1.95.

Trycera Financial, Inc. (TRYF)

Penny Stock Finder, Stock Hideout, and Bull Rally reported today on Trycera Financial, Inc. (TRYF), Greenbackers, Early Bird, Free Hot Penny Stocks, The pennystock picks, Hot Penny Stocks Now, Penny Stock Solutions, Stocks Gone Wild did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trycera Financial, Inc. is a financial services company specializing in the delivery of prepaid card programs, prepaid card program management, alternative credit products, and bill payment reporting. They also market a diverse suite of personal financial management solutions and pay as you go services that give consumers the ability to have alternative credit references such as rent, utilities, insurance, and wireless phone service payments reported with any application that requires a credit check and added to their credit scores. Trycera Financial, Inc. has their headquarters in Irvine, California.

The Company fulfills the needs of under-banked and credit-underserved consumers. Trycera is focused on two key distribution channels, business-to-consumer (B2C) and direct business-to-business (B2B). For consumers, Trycera provides consumer prepaid debit cards and an elective suite of personal financial management tools.

For businesses, Trycera provides co-branded prepaid card solutions and co-branded personal financial management solutions. The Company also provides consulting services to businesses seeking to enter into or expand their presence in the prepaid and personal financial management space.

This week, Trycera Financial, Inc. announced that they have entered into a licensing agreement with Simply Budgets. This is to allow Trycera prepaid cardholders’ access to card-based money management services that include budgeting, debt management, and savings tools.

Simply Budgets has sold their branded tools Simply Budgets, Debt Busters, and Simple Wealth Steps to consumers worldwide. In addition to helping people establish positive credit and trade lines, Trycera will now offer services designed to assist cardholders and consumers in managing their money. By partnering under a licensing agreement, the Company will link these three money management services to their prepaid debit card platform.

Today, Trycera Financial, Inc. announced that they have teamed up with GlobeWired (www.GlobeWired.com) to partner on strategic marketing campaigns. Through teaming up with GlobeWired, Trycera will be able to strategically market a suite of financial services to a broad spectrum of businesses and individuals and also promote financial welfare through employment opportunities. GlobeWired is a company that provides leading edge sales and marketing services by hiring agents and allowing them to maximize conversion effectiveness by working remotely.

Trycera Financial, Inc. (TRYF) closed Wednesday’s trading session at $0.05, down 7.69%, on 8,875,691 volume with 492 trades.  The average volume for the last 60 days is 28,688.  The 52-week low/high is $0.03/$0.135.

Sorrento Therapeutics, Inc. (SRNE)

We are highlighting Sorrento Therapeutics, Inc. (SRNE), here at the QualityStocks Daily Newsletter.

Founded in 2006, Sorrento Therapeutics, Inc. is a development-stage biopharmaceutical company headquartered in San Diego, California. They focus on applying and commercializing their proprietary technology platform, an extensive library of full-length, fully human monoclonal antibodies, for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions. This includes cancer, inflammation, metabolic, and infectious diseases.

In April 2010, Sorrento completed the construction of an extensive library of full-length, fully human mAbs. Initial analysis indicates a potential diversity of more than one trillion unique mAbs. The Company believes this makes their library the largest full-length, fully human antibody library available for drug discovery and development partnerships.

Their proprietary mammalian display system enables the expression and isolation of full-length human antibodies. In contrast, antibody libraries displayed in phage or yeast systems typically generate antibody fragments. These require further configuration into full-length antibodies for therapeutic development. Sorrento Therapeutics, Inc. uses fluorescence-activated cell sorting (FACS) to rapidly identify high-affinity antibody candidates from their library for immediate downstream development.

Sorrento believes the extensive diversity of their library of complete antibodies increases the likelihood of identifying candidates with optimal biological activity against validated disease targets. The Company applies a proprietary platform, the STI technology, for the construction of fully human antibody libraries.  The Company’s patented technology for the amplification and enrichment of the immunoglobulin variable domain sequences applies ribonucleic acid (RNA) transcription to ensure high representation of the vast diversity of the immunoglobulin gene repertoire. The library was created using an input of antibody-generating source cells from approximately 600 donors and covers all major classes of immunoglobulins (i.e. IgM, IgG1 - 4, IgA, IgD and IgE).

Sorrento Therapeutics, Inc.’s objective, either independently or through one or more partnerships with pharmaceutical or biopharmaceutical organizations, is to focus their efforts primarily in the identification and isolation of human antibody drug candidates derived from this library. If they are successful in developing and isolating any product candidates, the Company intends to actively seek partners with experience and expertise in the antibody drug development field in order to engage in any clinical development of these candidates.

Sorrento Therapeutics, Inc. (SRNE) closed Wednesday’s trading session at $0.60, up 0.00%, on 0 volume with 0 trades.  The average volume for the last 60 days is 350.  The 52-week low/high is $0.30/$3.00.

Oncothyreon Inc. (ONTY)

SmallCap Voice, Penny To Buck, Greenbackers, and The Street reported earlier on Oncothyreon Inc. (ONTY), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Oncothyreon Inc. is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. The Company’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. Oncothyreon Inc.’s shares trade on the NASDAQ Global Market. The Company has their corporate headquarters in Seattle, Washington.

Oncothyreon Inc. is currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. Their pipeline includes both synthetic vaccines and small molecules for a variety of cancer indications.

For Small Molecules, PX-866 targets the phosphatidylinositol-3-kinase (PI-3K) pathway. PX-866 is a small molecule drug that irreversibly inhibits phosphatidylinositol-3-kinase (PI-3K), a family of intracellular signaling molecules that play essential roles in multiple cellular functions. In normal cells the PI-3K pathway is tightly controlled, whereas the inappropriate activation of PI-3K is important in the pathogenesis of multiple human cancers, making it a rational and attractive target for drug development.

For Vaccines, Stimuvax® is a therapeutic vaccine designed to stimulate an individual's immune system to recognize cancer cells and control the growth and spread of cancers in order to increase the survival of cancer patients. Stimuvax incorporates a 25-amino acid sequence of the cancer-associated marker MUC-1 in a liposomal formulation. The vaccine is thought to work by stimulating a T-cell mediated immune response to cancer cells expressing the target MUC-1.

In addition, for Vaccines, ONT-10 is a therapeutic vaccine candidate designed to stimulate an individual's immune system to identify cancer cells and mount an immune response against those cells. ONT-10 is a liposomal vaccine composed of a 40 amino acid glyocoprotein sequence of the cancer-associated marker MUC-1. The ONT-10 adjuvant is a fully synthetic form of lipid A and is proprietary to Oncothyreon Inc. ONT-10 is designed to produce both an antibody and a T-cell immune response to cancer cells that express the MUC-1 target. IND enabling studies of ONT-10 are currently underway at Oncothyreon.

Recently, Oncothyreon Inc. reported a net loss for the quarter ended September 30, 2010 of $4.4 million or $0.17 per basic and diluted share, compared with a net loss of $6.0 million or $0.24 per basic and diluted share for the comparable period in 2009.  Oncothyreon also reported a net loss of $9.5 million or $0.37 per basic and diluted share for the nine months ended September 30, 2010, compared with a net loss of $14.7 million or $0.68 per basic and diluted share for the nine months ended September 30, 2009. 

Oncothyreon Inc. (ONTY) closed Wednesday’s trading session at $3.34, up 2.14%, on 86,534 volume with 338 trades.  The average volume for the last 60 days is 192,085.  The 52-week low/high is $2.15/$5.90.

Oculus Innovative Sciences, Inc. (OCLS)

SmallCap Voice, OTC Picks, Momentum Traders, StockMister.com, HotOTC.com, Cool Penny Stocks, Stock Stars, Stock Rich, Microcap Voice, Greenbackers, StockEgg.com, and Penny Invest reported earlier on Oculus Innovative Sciences, Inc. (OCLS), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Oculus Innovative Sciences, Inc. is a commercial medical technology company that trades on the NASDAQ Capital Market. The Company designs, produces, and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. Oculus Innovative Sciences, Inc. has their headquarters in Petaluma, California. They have manufacturing operations in the United States and Latin America. They conduct operations in Europe and Latin America through their wholly owned subsidiaries, Oculus Innovative Sciences Netherlands B.V., Oculus Technologies of Mexico, S.A. de C.V.

Microcyn Technology is a unique shelf-stable pH-neutral oxychlorine compound. The Microcyn® Technology addresses the need for improved solutions in multiple markets. This includes dermatology, oral care, cosmeceutical, wound care, and others. It features a biocompatible, shelf-stable solution that is currently commercialized in the United States, Europe, India, China, and Mexico and select Middle East countries under various country specific regulatory clearances and approvals.

Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens. This includes antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi, and spores; increasing blood flow to the wound site; and reducing both inflammation and pain while assisting in faster wound closure.

Last week, Oculus Innovative Sciences, Inc. announced that they have entered into a definitive agreement with Onset Therapeutics. Under this agreement, Oculus and Onset Therapeutics will work together to bring unique products to the U.S. dermatology market. They are initially targeting atopic dermatitis and related conditions, while leveraging Oculus’ unique Microcyn Technology platform and Onset’s strong national-commercial presence with a 35-person dermatology sales team. Oculus has received FDA clearance and commercialized two Microcyn-based dermatology products in the United States, a spray solution and a hydrogel.

In addition, last week, Oculus Innovative Sciences, Inc. introduced XuSorb™ Foam Wound Dressing with a waterproof polyurethane covering for the U.S. professional wound care and surgical market. XuSorb™ Foam is able to absorb four times more exudate than hydrocolloids. The latex-free XuSorb Foam delivers optimum results when applied to a wound following use of the Company’s Microcyn-based wound care products.

XuSorb Foam is a non-adhesive Microcyn-compatible foam dressing that delivers superior fluid handling while providing a barrier to contamination. It is suitable for many types of exuding wounds including leg ulcers, pressure ulcers, donor sites, and partial- and full-thickness wounds. XuSorb maintains a moist wound-healing environment while its semi-permeable polyurethane covering permits water vapor transmission away from the wound.

Oculus Innovative Sciences, Inc. (OCLS) closed Wednesday’s trading session at $1.75, up 8.70%, on 104,680 volume with 152 trades.  The average volume for the last 60 days is 52,984.  The 52-week low/high is $1.35/$3.20.

Monster Offers (MONT)

Today we are highlighting Monster Offers (MONT), here at the QualityStocks Daily Newsletter.

Monster Offers is an emerging online technology company that trades on the OTC Bulletin Board. The Company specializes in social media commerce and advertising solutions for large Companies and Non Profit Organizations. The Monster Offers company website is www.monsteroffers.com.

Monster Offers is an aggregator and publisher of local daily deals on the Internet. Using their advanced technology, the Company’s team scours the web and brings people the best daily deals every day. They display offers from all the top daily deal sites, all in one place, each day.

Monster Offers introduced the Social Network Channel™ (SCN). This is a breakthrough technology platform that places Social Marketing at the center of the marketing world and the hub of today's business enterprise. Their Social Networking and Commerce solutions are based on proven infrastructure and Service Oriented Web 3.0 Architecture designed for the social Web, and can be easily integrated with other existing technologies, the latest social media and marketing communications solutions.

Consequently, legacy technology can be integrated and communicate with new technology. When the need for new technologies arises, they can be added without changing the core architecture. This means that a client saves money and has a long lasting foundation for their technology, essentially "future-proofing" their investment.

In addition, it is a framework for integrating information, people, and processes across organizational boundaries. It provides a secure single sign-on and unified access point, in the form of a web-based user interface and is designed to aggregate and personalize information through application-specific components and portlets.

Yesterday, Monster Offers launched a Webinar series designed to help newspapers compete in the Deal-of-the-Day space. Quantitative and qualitative research findings and conclusions were made after studying 70-plus programs operating in markets throughout the country. Representatives from many of the largest newspaper organizations attended the first Webinar to learn more about the growth opportunity presented by the business model developed by Groupon approximately 18 months ago. The proprietary research and Webinar series is scheduled to continue as Monster Offers develops additional business solutions, products and services to help support newspaper programs.

Today, Monster Offers announced the acquisition of DrHealthShare.com, a Web 3.0 social commerce solution for health and wellness that empowers like-minded collaborators to harness the collective knowledge and experience of the social crowd to improve the depth, breadth, and value of health information. DrHealthShare brings together people from around the world to ask their health questions and to share experiences, and inspirational stories. Monster Offers plans to integrate the DrHealthShare community into its suite of business solutions.

Monster Offers CEO, Paul Gain, said, “We see a core value in how DrHealthShare organizes information, and provides relevant search results to health advice-seekers. As a business solution provider, we will offer social media strategy, guidance, and implementation services to health-oriented partner companies and advertisers within the healthcare industry.”

Monster Offers (MONT) closed Wednesday’s session at $1.12, up 6.67%, on 584,743 volume with 248 trades.  The average volume for the last 60 days is 18,745.  The 52-week low/high is $0.60/$1.05.

Entropic Communications, Inc. (ENTR)

Wall Street Resources reported recently on Entropic Communications, Inc. (ENTR), SmallCap Voice did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Founded in 2001, Entropic Communications, Inc. is a leading fabless semiconductor company that trades on the NASDAQ Global Market. They are engineering the future of connected home networking and entertainment by providing next-generation silicon and software technologies to the world's leading cable, telecommunication carriers, and satellite service providers, OEMs and consumer electronics manufacturers. Entropic Communications, Inc. has their corporate headquarters in San Diego, California.

As a co-founder of MoCA (Multimedia over Coax Alliance), Entropic pioneered and continues to evolve the way high-definition television-quality video and other multimedia and digital content such as movies, music, games, and photos are brought into and delivered throughout the home. The Company’s products include home networking chipsets based on the MoCA standard, high-speed broadband access chipsets, integrated circuits, or ICs, that simplify digital broadcast satellite, or DBS, services, and silicon TV tuner ICs.

The Company’s products allow telecommunication carriers, cable multiple service operators, or MSOs, and DBS service providers to enhance and expand their service offerings and reduce deployment costs in an increasingly competitive environment. Their home networking solutions capitalize on the global conversion of multimedia content from analog to digital.

Entropic Communications Inc. is the only high-volume supplier of MoCA-compliant chipsets, which can be embedded in a broad spectrum of consumer electronic devices. Service providers can employ the Company’s solutions to offer consumer applications such as multi-room DVR, multi-room and online gaming, PC to TV personal content sharing, and streaming of downloaded movies stored on a PC to any TV.

The Company’s silicon solutions are currently used in consumer electronic and networking devices. These include Set-Top Boxes [STBs], Broadband Routers, Optical Network Terminals [ONTs], Low Noise Block Converters [LNBs], Multi-Room Digital Video Recorders [DVRs], Residential Gateways, Single Wire Multi-Switches [SWM] and Ethernet to Coax Bridges [ECB]. Their solutions also have potential applications in digital TVs, gaming consoles, media servers, home media gateways, and network attached storage devices.

Last week, Entropic Communications, Inc. announced that they have been selected as a winner for the 2010 TechAmerica High Tech Awards. The Company’s MoCA (multimedia over coax alliance) silicon solution was recognized in the Communications Products and Services category. Their MoCA silicon was noted for its ability to provide the high-speed and robust backbone for connected home entertainment networking. Entropic's MoCA silicon is currently being deployed by nearly all major North American pay-TV service providers. This includes Verizon FiOS, DIRECTV, Comcast, Cox Communications, and Time Warner Cable.

Entropic Communications, Inc. (ENTR) closed Wednesday’s trading session at $8.47, down 1.19%, on 1,406,269 volume with 8,283 trades.  The average volume for the last 60 days is 2,926,887.  The 52-week low/high is $2.80/$10.35.

Central Resources Corporation (CBC.V)

We are highlighting Central Resources Corporation (CBC.V), here at the QualityStocks Daily Newsletter.

Central Resources Corporation is a junior mineral exploration company created to leverage the extensive knowledge and experience of a dedicated group of financial and resource industry professionals. The Company has acquired options on several highly prospective mineral properties in the White Gold District of central Yukon. Founded in 2007, Central Resources Corporation trades on the TSX Venture Exchange. They have their headquarters in Vancouver, British Columbia.

The Company’s White Gold Properties are located in the Dawson Range, south of the Yukon River, roughly 200 km southeast of Dawson City, Yukon. This area of the Yukon is known for its historical mining of placer gold deposits and more recent discoveries of epithermal style lode gold and porphyry related copper-gold-moly mineralization. Central's White Gold Properties are generally underlain by metasedimentary and metavolcanic rocks (schists and gniesses) of inferred Devonian to Mississippian age, which are intruded by numerous Mesozoic granitic plutons (granodiorites) associated with copper, molybdenum, and gold mineralization.

The Company also has their Newman Todd project in Ontario, Canada.  The Newman Todd property is located in the prolific Red Lake Mining Camp of northwestern Ontario which is host to over 30 million ounces past production and current reserves. Situated 35 km west of the town of Red Lake, the property consists of 13 patented claims totaling 195 hectares.

In addition, Central Resources has their Tam property in British Columbia, Canada. The Tam property is located in the Quesnel Trough area of B.C., approximately 21 kilometers northeast of Lac La Hache, and is accessible by good gravel roads. The claims cover an area of 900 hectares and are underlain by altered volcanics and alkalic intrusives similar in age and lithology to those which underlie the Mt. Polley and QR deposits.

Recently, Central Resources announced additional results from the initial program of soil sampling at the Company's 522-claim (10,917 hectares) Selwyn Creek Gold project in the White Gold Area of central Yukon. The latest results for the East Zone of the "L" Block extend the existing gold anomaly by approximately 400m, defining a roughly linear, greater than 20 ppb gold anomaly, at least 1,000 meters in strike length.

The Selwyn Creek Gold project consists of 6 separate claim blocks (J, K, L, M, N, O) located in the Dawson Range, south of the Yukon River and centered on Selwyn Creek. The properties were staked on the basis of historic anomalous soil and sediment sampling conducted by Archer Cathro & Associates Ltd. in the mid 1980's. Central Resources has the right to earn a 100 percent interest in the properties from Strategic Metals Ltd., by making payments of $300,000 cash and 3,000,000 shares by February 15, 2012.

Central Resources Corporation (CBC.V) closed Wednesday’s trading at $0.16, up 6.67%, on 167,800 volume.  The 52-week low/high is $0.09/$0.40.

The QualityStocks Company Corner

Uranium Energy Corp. (UEC)

The QualityStocks Daily Newsletter would like to spotlight Uranium Energy Corp. (UEC) Today, the Uranium Energy Corporation closed trading at $5.24, up 7.38%, on 988,063 volume with 2,683 trades.  The average 60-day volume is 873,376 with a 52-week low/high of $2.11/$6.18.

Uranium Energy Corp. (UEC) was pleased to announce this morning that it has started uranium production using in-situ recovery (ISR) methods at the Palangana Project in South Texas. The company reported successful completion of phase I of three separate development phases of the wellfield at Production Area 1 (PAA-1), with more than 45 injection wells and production wells drilled, cased and tested.

Uranium Energy Corp. (UEC) is a U.S.-based exploration and development company focused on near-term uranium production in the U.S. The company’s operations are managed by professionals who have earned a reputable profile through many decades of hands-on experience in the key facets of uranium exploration, development and mining.

Uranium Energy controls one of the largest databases of historic uranium exploration and development in the nation. Using this knowledge base, the company has acquired and is advancing exploration properties of merit throughout the southwestern U.S., a region known as being the most concentrated area for uranium mining in the United States.

The Company’s fully licensed and permitted Hobson processing facility is central to all of its projects in South Texas. Well financed to execute on its key programs, Uranium Energy's Palangana is-situ recovery project is fully permitted, and its Goliad in-situ recovery project is in the final stages of mine permitting for production.

The company’s strategy of acquiring exploration databases and leveraging those databases to generate acquisition targets has proven to be effective thus far. With plans to continue aggressively pursuing this strategy, Uranium Energy Corp is well positioned to capitalize on the world’s first significant alternative energy boom. Disclaimer

Uranium Energy Corp. Blog

Uranium Energy Corp. News:

Uranium Energy Corp Begins Production at Palangana ISR Project

Uranium Energy Corp Completes $27.5 Million Financing

Uranium Energy Corp Announces Private Placement

True 2 Beauty (TRTB)

The QualityStocks Daily Newsletter would like to spotlight True 2 Beauty (TRTB). Today, True 2 Beauty closed trading at $0.17, up 11.33%, on 38,950 volume with 8 trades.  The average 60-day volume is 70,130 with a 52-week low/high of $1.00/$0.02.

True 2 Beauty (TRTB) is a leading manufacturer and distributor of sexual potency pills and liquid products in the United States, with expansion efforts underway in other parts of the world. The company's line of current products currently include Libigrow (for men), Libigirl (for women), Libiliquid Shots and Libiliquid Relaxation Drinks. Made from only natural ingredients, the products are regarded as the most powerful over the counter herbal sexual and performance supplements available on the market.

In addition to being sold online, Libigrow products are sold throughout the U.S. in convenience stores, liquor stores, smoke shops, vitamin stores, independent grocers, and adult boutique stores, with potential in larger chains such as CVS, Walgreens and GNC to name a few. In fact, a major retail pharmacy chain has begun a regional trial in eight of their stores in southern Florida in preparation for a nationwide roll-out to begin in early 2011 for select Libigrow products – the first step to national expansion within the retail pharmacy chain network.

The company has recruited a trained and highly qualified full-time staff. In addition to their talented and well-seasoned designers, the company employs a team of photographers, web designers, a marketing and advertising director and assistant director, account managers in sales, in-house customer service representatives, a commercial ads designer and editor, and an in-house printing team for all promotional material.

Alex Hbaiu leads the company as CEO, president and director. He published several research articles and findings during his employment at Eli Lily Research Labs where he had the opportunity to work with some of the most talented and educated doctors and scientists in the world. Although founded with very little capital, via Mr. Hbaiu's expert leadership Librigrow has grown to over $10,000,000 in sales via "word of mouth" advertising alone. Disclaimer

True 2 Beauty Blog

True 2 BeautyNews:

True 2 Beauty, Inc. Expands Production With New 39,000 Square Ft Building in City of Commerce, California

True 2 Beauty Inc. Receives Tremendous Response From the Market Embracing TRTB as a New Company With Rapidly Growing Revenue

True 2 Beauty Announces Five Million Dollar Private Placement To Increase Production Capacity of "Libigrow" Family of Products

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDoorways Corporation closed trading at $0.0021, up 10.53%, on 1,830,741 volume with 15 trades. The stock’s average daily volume over the past 60 days 3,315,463 with a 52-week low/high of $0.0011/$0.09.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways International Corporation Retains ATG Capital Solutions to Assist with Investor Relations

eDoorways International Corporation Closes Multi-Million Dollar Financing Deal

eDoorways International Corporation Unveils New Technology to the International Marketplace

IDO Security Inc. (IDOI)

The QualityStocks Daily Newsletter would like to spotlight IDO Security Inc. (IDOI). Today, IDO Security Inc. closed trading at $0.0016, down 5.88%, on 19,804,233 volume with 113 trades.  The average 60-day volume is 46,632,445 with a 52-week low/high of $0.0004/$0.0061.

IDO Security, Inc. (IDOI), headquartered in New York with a subsidiary in Israel, focuses on developing solutions for shoes-on weapons metal detection. The company's flagship product, the patented MagShoe™ system, instantly and accurately detects metal items concealed on or in footwear, ankles or feet without requiring the removal of shoes. Taking only 3-4 seconds to scan, the detection system solves possibly the most problematic issue in the security checkpoint routine.

The MagShoe is produced at the company's main manufacturing facility in Rishon LeZion, Israel where it offers local sales and support via a worldwide network of industry-leading distributors and system integrators. Designed for security and loss prevention at high-security venues and checkpoints, IDO Security's products are currently in use at international airports, cruise lines, government agencies and other locations requiring strong security.

The company's detection systems employ state-of-the-art sensors and algorithms to detect weapons and other controlled metal articles. By providing accurate measurements, the MagShoe solutions keep false alarms at minimum - detecting potentially dangerous items while ignoring metal typically found in footwear such as heels, zippers and ornaments. The advanced technology reduces the number of manual inspections required, allowing personnel to focus on the real threat.

President and Director Michael L. Goldberg guides the direction of the company with an extensive business and legal background spanning more than 30 years. Prior to joining IDO Security, Mr. Goldberg spent 17 years as the Chairman, CEO and one-time President of RX Medical Services, a medical company that owned and operated small rural hospitals, clinical laboratories and MRI/CT centers across the US. He has served on the boards and as a member of audit and compensation committees for a number of public companies.

IDO Security Inc. (IDOI Blog

IDO Security Inc. News:

IDO Security Delivers First Order for the New MagShoe(TM) 3G Weapons Metal Detection System to Spain

IDO Security, Inc. Introduces New Safety Rails System Designed to Complement the MagShoe(TM) 3G Series

IDO Security Expands Presence in Europe

Consorteum Holdings, Inc. (CSRH) Offers Clients Creative Ways to Save Money and Increase Sales

With the many and varied initiatives and projects that Consorteum Holdings has been involved in recently, it’s easy for investors to lose sight of its foundational strengths and primary strategy in the marketplace.

Consorteum Holdings Inc. is making a name for itself in the financial services, payment, and transaction processing industries. As made clear on their website, the company provides electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. They create customized, innovative technology solutions to augment and enhance their client’s existing financial, payment, and transactional processing systems. The idea is to allow clients to spend less time dealing with transaction processing issues, and more time focusing on their core competencies.

Perhaps more importantly, Consorteum utilizes the latest technologies to create dynamic customer oriented programs that let clients draw in new customers while better cultivating their existing customer base. Since Consorteum is not locked into its own technologies, it is free to source the best solutions worldwide, allowing them to come up with truly creative approaches.

For example, Consorteum puts together customized loyalty programs for clients, strengthening brand loyalty and market share by encouraging repeat buying and more revenue per purchase. They also offer sophisticated card-based payroll programs, making it easier for client companies to pay employees, especially un-banked or under-banked employees. In addition, Consorteum offers efficient solutions to the health and wellness industry, by providing better ways for patients to track and manage health related records and financial data. Consorteum offers more efficient rebate systems, gift card programs, benefit cards, and many other ways to help their clients reduce costs and increase revenue.

Uranium Energy Corp. (UEC) Announces Initiation of Production at Palangana ISR Project

Uranium Energy Corp. was pleased to announce this morning that it has started uranium production using in-situ recovery (ISR) methods at the Palangana Project in South Texas.

The company reported successful completion of phase I of three separate development phases of the wellfield at Production Area 1 (PAA-1), with more than 45 injection wells and production wells drilled, cased and tested. Uranium Energy said it was very pleased with the water volume that each well yielded during the testing phase. Now the company is adding gaseous oxygen and carbon dioxide to the circulating ground water to activate the mining process of dissolving the uranium from surrounding sandstones.

Amir Adnani, President and CEO, exclaimed, “We are exceedingly proud that Palangana is the first new ISR uranium mine to achieve production in the U.S. in over 5 years. Kudos are due to our many professionals who have been working very hard to reach this important milestone. Palangana is one of the Company’s four projects in South Texas. This initial production is really just the first step in the Company’s regional strategy of greatly expanding resources and production in the re-emerging South Texas Uranium Belt, with the next project, the nearby Goliad ISR project, anticipated to join Palangana as a producing asset next year.”

Harry Anthony, Chief Operating Officer, commented, “The next milestone will be the start of regular deliveries of uranium-loaded resin beads to our Hobson processing plant, scheduled to commence before month-end. Shortly thereafter, we will be marketing and delivering yellowcake, the Company’s valuable final product. Hobson is a newly refurbished, state-of-the-art processing plant, and anchors the Company’s South Texas regional strategy with up to 3.0 million pounds of annual capacity.”

Phases II and III of the PAA-1 wellfield each will also contain 45 production and injection wells. According to today’s press release, all Phase II wells have already been completed and are targeted to commence mining in the first quarter of next year. Installation of Phase III wells is underway with three rigs actively casing and then completing each well. Uranium Energy anticipates these wells to come on-line and start production during the second quarter of 2011.

CaseyCorp Enterprises, Inc. (CCPR) to Strategically Establish a Market Leading Position

Through its operating subsidiary ESM Refiners (ESM), Casey Corp. is primarily focused on recycling precious metals, mainly gold. ESM is an aggregator which purchases jewelry and other items containing gold from retail stores and other sources and then sells the jewelry to refineries which in turn melt down the gold and produce gold bars.

Traditionally, gold aggregation is a high volume, low margin business. The largest share of the profits, commonly over 60%, remains with the retail store, pawn shop or other party which purchased the gold items from their original owners. On average, the aggregator keeps just 1% of the refined gold value.

By leveraging its extensive knowledge of the gold market and strategically investing in new initiatives, the company plans to increase its coverage of the supply chain for greater revenues and profitability. The first phase of expansion consists of establishing an independent refining facility. The second phase consists of developing its online business to purchase gold items directly from the original owners.

By being a fully integrated vertical operator, ESM will retain the full profit of the gold jewelry recycling process. The company’s management team is confident that the availability of investment will support heavy marketing and promotional activity, enabling the company to become one of the leading players in the market.

Asia Pacific Wire & Cable (AWRCF) Posts Solid Nine-Month Figures

Asia Pacific Wire & Cable Corp. is a leading manufacturer and distributor of telecommunications and power cable and enameled-wire products in the Asia-Pacific region, with a primary focus on China, Thailand, Singapore and Australia. The company today reported its unaudited consolidated results for the nine-month period ended September 30, 2010, reflecting strong demand for its enameled wire and power cable products in Thailand and China.

Revenues for the nine-month period were $325.2 million, a 28.8-percent increase over the $252.4 million reported for the comparable nine-month period of 2009.
For the nine-month period of 2010, the company posted gross profit of $40.8 million, a 27.5-percent increase from $32.0 million reported in the same period a year ago; gross margins were 12.5 percent for the nine-month period of 2010 versus 12.7 percent in 2009.

Asia Pacific reported net income attributable to shareholders at $11.1 million, or $0.80 per basic and diluted earnings per share, for the nine-month period ended September 30, 2010, a 91.4 percent increase from $5.8 million, or $0.42 basic and diluted earnings per share, in the same period a year ago.

Operating income for the nine-months ended September 30, 2010, was $19.8 million, a 104.1-percent increase compared to $9.7 million reported in the year-ago period.

As of September 30, 2010, Asia Pacific had $50.1 million in cash and cash equivalents, compared to $41.5 million as of December 31, 2009. Total current assets were reported at $294.4 million as of September 30, 2010, compared to $239.0 million at the end of 2009.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Reports a Successful Webinar Presentation of the Technologies and Operations of Its Bacterial Identification System



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336